2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Osteolysis: new trials by email Literature Review of Osteolysis trials Research Report on Osteolysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Denosumab for Treating Periprosthetic Osteolysis. Denosumab, Placebo - Osteolysis | Phase 2 | Unknown | Olof Skoldenberg | 20 | 2015-08-01 | 2019-02-07 |
| Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma Tivantinib, Diagnostic laboratory biomarker analysis, Questionnaire administration - Refractory Multiple Myeloma | Phase 2 | Completed | National Cancer Institute (NCI) | 16 | 2011-11-01 | 2019-08-28 |
| Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements Placebo, Apatone®B - Edematous, Synovitis | Phase 2 | Completed | IC-MedTech Corporation | 57 | 2010-10-01 | 2018-01-31 |
Amyloidosis (1) · Anemia (1) · Bone Diseases, Metabolic (1) · Edema (1) · Foreign-Body Reaction (1) · Fractures, Spontaneous (1) · Hematologic Neoplasms (1) · Hypercalcemia (1) · Multiple Myeloma (1) · Paraproteinemias (1) · Renal Insufficiency (1) · Synovitis (1)
Bone Diseases (3) · Bone Resorption (3) · Musculoskeletal Diseases (3) · Wounds and Injuries (2) · Blood Protein Disorders (1) · Calcium Metabolism Disorders (1) · Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Foreign Bodies (1) · Fractures, Bone (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1)
IC-MedTech Corporation (1) · National Cancer Institute (NCI) (1) · Olof Skoldenberg (1)
United States (2) · Sweden (1)
Mark W Kovacik, BS (1) · Robert Orlowski (1) · Thomas F Bear, MD (1)
N01CM00039 (1), P30CA016672 (1), U01CA062461 (1)